MYDRIATIC-3- tropicamide - cyclopentolate - phenylephrine solution/ drops

Country: Amerika Syarikat

Bahasa: Inggeris

Sumber: NLM (National Library of Medicine)

Beli sekarang

Download Ciri produk (SPC)
08-05-2018

Bahan aktif:

TROPICAMIDE (UNII: N0A3Z5XTC6) (TROPICAMIDE - UNII:N0A3Z5XTC6), CYCLOPENTOLATE HYDROCHLORIDE (UNII: 736I6971TE) (CYCLOPENTOLATE - UNII:I76F4SHP7J), PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV)

Boleh didapati daripada:

Imprimis NJOF LLC

Laluan pentadbiran:

OPHTHALMIC

Jenis preskripsi:

PRESCRIPTION DRUG

Status kebenaran:

unapproved drug other

Ciri produk

                                MYDRIATIC-3- TROPICAMIDE - CYCLOPENTOLATE - PHENYLEPHRINE SOLUTION/
DROPS
IMPRIMIS NJOF LLC
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
STORE AT 20° TO 25° C (68° TO 77° F)
MYDRIATIC-3
tropicamide - cyclopentolate - phenylephrine solution/ drops
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN PRESCRIPTION DRUG
ITE M CODE (SOURCE )
NDC:7138 4-6 31
ROUTE OF ADMINISTRATION
OPHTHALMIC
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
TRO PICAMIDE (UNII: N0 A3Z5XTC6 ) (TROPICAMIDE - UNII:N0 A3Z5XTC6 )
TROPICAMIDE
10 mg
in 1 mL
CYCLO PENTO LATE HYDRO CHLO RIDE (UNII: 736 I6 9 71TE) (CYCLOPENTOLATE
- UNII:I76 F4SHP7J)
CYCLOPENTOLATE
HYDROCHLORIDE
10 mg
in 1 mL
PHENYLEPHRINE HYDRO CHLO RIDE (UNII: 0 4JA59 TNSJ) (PHENYLEPHRINE -
UNII:1WS29 7W6 MV)
PHENYLEPHRINE
HYDROCHLORIDE
25 mg
in 1 mL
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:7138 4-6 31-
0 5
5 mL in 1 BOTTLE, DROPPER; Type 0 : No t a Co mbinatio n
Pro duc t
0 5/0 1/20 18
Imprimis NJOF LLC
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 5/0 1/20 18
LABELER -
Imprimis NJOF LLC (080431967)
Revised: 5/2018
                                
                                Baca dokumen lengkap